RecallHawk

IMIPRAMINE HYDROCHLORIDE

STRIDES PHARMA INTL

Summary

FDA approved IMIPRAMINE HYDROCHLORIDE by STRIDES PHARMA INTL. ANDA (Generic) approval (Labeling) on 2025-06-24. TABLET, ORAL.

Details

Source

Drug Approval

External ID

ANDA088292-42

Action Date

2025-06-24

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

IMIPRAMINE HYDROCHLORIDE, TABLET, ORAL. Application: ANDA088292

Context & Analysis

STRIDES PHARMA INTL has 30 FDA actions in our database.

Frequently Asked Questions

How often does STRIDES PHARMA INTL have FDA actions?

STRIDES PHARMA INTL has 30 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA088292-42" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions